GLUT4 as A Protein Target for T2DM Therapy with Natural Compounds
WHO reported 1.9 million death cases of diabetes patients in 2019. Diabetes is caused by damage in the pancreas which resulted in a lack of insulin or insulin resistance. Medication for T2DM mainly focuses on lowering blood glucose and treating affected organs. Current medications are still lacking,...
Main Authors: | Vivi Hendra Sutandar, Mgs. Irsan Saleh, Ziske Maritska |
---|---|
Format: | Article |
Language: | English |
Published: |
State Islamic University Sunan Kalijaga
2023-03-01
|
Series: | Biology, Medicine & Natural Product Chemistry |
Subjects: | |
Online Access: | https://sciencebiology.org/index.php/BIOMEDICH/article/view/317 |
Similar Items
-
Hypoglycemic Effect of Nelumbo Nucifera Seed Extract on GLUT-4 mRNA and GLUT-4 Protein in Streptozotocin-Induced Diabetic Rats
by: Neha Pipil, et al.
Published: (2023-01-01) -
Association of single nucleotide polymorphisms of miRNAs involved in the GLUT4 pathway in T2DM in a Chinese population
by: Yiping Li, et al.
Published: (2019-09-01) -
Nuciferine relieves type 2 diabetes mellitus via enhancing GLUT4 expression and translocation
by: Tongxi Zhou, et al.
Published: (2023-11-01) -
Elucidating the Potential Inhibitor against Type 2 Diabetes Mellitus Associated Gene of GLUT4
by: Afaf Aldahish, et al.
Published: (2023-04-01) -
Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?
by: Peter R.T. Bowman, et al.
Published: (2021-05-01)